| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 药品(元) | 375,542,276.23 | 531,529,198.98 | 239,318,417.23 | 383,557,256.20 | 217,165,064.44 |
| 医药中间体(元) | 92,706.80 | - | 1,332,442.79 | 2,805,075.22 | 2,732,508.85 |
| 资产租赁(元) | 15,290.52 | - | 45,871.56 | 76,452.60 | 30,581.04 |
| 营业成本(元) | |||||
| 药品(元) | 38,779,644.70 | 34,278,370.56 | 16,281,615.31 | 28,209,030.63 | - |
| 医药中间体(元) | 37,419.13 | - | 1,202,812.37 | 983,809.82 | - |
| 资产租赁(元) | 3,851.10 | - | 11,553.30 | 19,255.50 | - |
| 毛利(元) | |||||
| 药品(元) | 336,762,631.53 | 497,250,828.42 | 223,036,801.92 | 355,348,225.57 | - |
| 医药中间体(元) | 55,287.67 | - | 129,630.42 | 1,821,265.40 | - |
| 资产租赁(元) | 11,439.42 | - | 34,318.26 | 57,197.10 | - |
| 毛利率(%) | |||||
| 药品(%) | 89.67 | 93.55 | 93.20 | 92.65 | - |
| 医药中间体(%) | 59.64 | - | 9.73 | 64.93 | - |
| 资产租赁(%) | 74.81 | - | 74.81 | 74.81 | - |
| 收入构成(%) | |||||
| 药品(%) | 99.97 | 100.00 | 99.43 | 99.25 | 98.74 |
| 医药中间体(%) | 0.02 | - | 0.55 | 0.73 | 1.24 |
| 资产租赁(%) | 0.00 | - | 0.02 | 0.02 | 0.01 |
| 毛利构成(%) | |||||
| 药品(%) | 99.98 | 100.00 | 99.93 | 99.47 | - |
| 医药中间体(%) | 0.02 | - | 0.06 | 0.51 | - |
| 资产租赁(%) | 0.00 | - | 0.02 | 0.02 | - |